New JerseyAuthorizes medical cannabis for treatment of sickle cell anemia.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jan 12Approved P.L.2025, c.223.Became Law
- 2025
- Dec 22Passed Senate (Passed Both Houses) (37-0)Passed 2nd Chamber
- Vote recorded 3RDG FINAL PASSAGE. Result: pass.Upper
- Dec 22Substituted for S2392
- Dec 15Reported out of Senate Committee, 2nd ReadingMinor
- Vote recorded Reported favorably out of committee. Result: pass.Upper
- Dec 11Referred to Senate Budget and Appropriations CommitteeMinor
- Nov 13Reported out of Senate Committee, 2nd ReadingMinor
- Vote recorded Reported favorably out of committee. Result: pass.Upper
- May 29Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens CommitteeMinor
- May 22Passed Assembly (71-2-4)Passed 1st Chamber
- Vote recorded 3RDG FINAL PASSAGE. Result: pass.Lower
- Mar 20Reported out of Assembly Committee, 2nd ReadingMinor
- Vote recorded Reported favorably out of committee. Result: pass.Lower
- Mar 6Reported and Referred to Assembly Appropriations CommitteeMinor
- Vote recorded Reported favorably out of committee. Result: pass.Lower
- Dec 22Passed Senate (Passed Both Houses) (37-0)Passed 2nd Chamber
- 2024
- Jan 9Introduced in the Assembly, Referred to Assembly Health CommitteeIntroduced